Phillip Eric Lee

Phillip Eric Lee

Director of Finance/CFO at VAXART, INC.

Net worth: 195 438 $ as of 2024-05-30

37 year
Health Technology
Finance
Consumer Services

Profile

Phillip Eric Lee's current job is Chief Financial Officer at Vaxart, Inc. His former jobs include Senior Director at Cytokinetics, Inc., Associate Director at Adverum Biotechnologies, Inc., Senior Director & Vice President at 4D Molecular Therapeutics, Inc., and Principal at Centerview Partners LLC.
He also served as Chief Financial & Business Development Officer at Clover Biopharmaceuticals Ltd.
Mr. Lee obtained his undergraduate degree from the University of California, Berkeley.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-06-11 239,801 ( 0.14% ) 195 438 $ 2024-05-30

Phillip Eric Lee active positions

CompaniesPositionStart
VAXART, INC. Director of Finance/CFO 2022-12-18
All active positions of Phillip Eric Lee

Former positions of Phillip Eric Lee

CompaniesPositionEnd
CLOVER BIOPHARMACEUTICALS, LTD. Director of Finance/CFO 2022-06-30
4D MOLECULAR THERAPEUTICS, INC. Director/Board Member 2020-12-31
CYTOKINETICS, INCORPORATED Director/Board Member 2018-02-28
ADVERUM BIOTECHNOLOGIES, INC. Corporate Officer/Principal 2015-12-31
Corporate Officer/Principal 2015-06-30
See the detail of Phillip Eric Lee's experience

Training of Phillip Eric Lee

University of California, Berkeley Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Phillip Eric Lee's experience

Connections

75

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
CLOVER BIOPHARMACEUTICALS, LTD.

Health Technology

ADVERUM BIOTECHNOLOGIES, INC.

Health Technology

CYTOKINETICS, INCORPORATED

Health Technology

4D MOLECULAR THERAPEUTICS, INC.

Health Technology

VAXART, INC.

Health Technology

Private companies1

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Phillip Eric Lee